# Designing Agentic AI-Based Screening for Portfolio Investment

arXiv: https://arxiv.org/abs/2603.23300 · HTML: https://mlsanity.com/paper/2603.23300/

## Key facts

- Cited by 1 papers in the map (data through 14 Oct 2026).
- Placed in Financial trading and forecasting agents, one of 16 directions in LLM agents and tool use.
- Builds on 2 of its 54 references that are in the map.
- First posted on arXiv 24 Mar 2026.

## Placed in

- LLM agents and tool use / [Financial trading and forecasting agents](https://mlsanity.com/agents/financial-trading-and-forecasting-agents/)

## Builds on (most cited first, 2 of 2)

- [Measuring Massive Multitask Language Understanding](https://mlsanity.com/paper/2009.03300/) (2020)
- [FinBERT: Financial Sentiment Analysis with Pre-trained Language Models](https://mlsanity.com/paper/1908.10063/) (2019)

## Built on by (most cited first, 1 of 1)

- [Agentic Trading: When LLM Agents Meet Financial Markets](https://mlsanity.com/paper/2605.19337/) (2026)

## Abstract (arXiv)

We introduce a new agentic artificial intelligence (AI) platform for portfolio management. Our architecture consists of three layers. First, two large language model (LLM) agents are assigned specialized tasks: one agent screens for firms with desirable fundamentals, while a sentiment analysis agent screens for firms with desirable news. Second, these agents deliberate to generate and agree upon buy and sell signals from a large portfolio, substantially narrowing the pool of candidate assets. Finally, we apply a high-dimensional precision matrix estimation procedure to determine optimal portfolio weights. We show, through information acquisition theory, that screening with agentic AI can bring utility gains in screening compared with humans. We introduce the concept of sensible screening and establish that, under mild screening errors, the squared Sharpe ratio of the screened portfolio consistently estimates its target. Empirically, our method achieves superior Sharpe ratios relative to an unscreened baseline portfolio and to conventional screening approaches, evaluated on S&P~500 data over both short and medium terms.
